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injection, the signal of the CSF cisterns became enhanced on T1-weighted images ( Figure 1A ). Sequential MRI revealed that the gadolinium chelate progressively entered the brain. The pathways of CSF distributions were consistent with previous reports 2 ( Figure 1B ). At 60 minutes postinjection, the contrast material reached all the brain regions ( Figure 1C ). Thus, our modified contrast-enhanced MRI protocol allowed imaging of the brain glymphatic system in mice. Interestingly, other routes of CSF drainage were also revealed by this protocol, including the ethmoid sinus, peritracheal lymph nodes, optic nerves, and the cochleovestibular region ( Figure 1D ).
Glymphatic System Is Impaired After SAH
Then, we looked for potential effects of SAH on the glymphatic system. We induced SAH by injection of 50 μL fresh arterial blood in the prechiasmatic cistern of mice. 4 Interestingly, 24 hours after SAH induction, the glymphatic system appeared severely impaired as compared with sham animals. Indeed, 60 minutes after intracisternal microinjection of DOTA-Gd, enhancement was present in the cerebellum but spared the forebrain (Figure 2A ), suggesting occlusion of para-arterial influx routes. We confirmed these results by immunohistology after injection of sodium fluorescein in the cisterna magna ( Figure 2B ). Importantly, this glymphatic blockade persisted after bilateral craniectomy ( Figure III in the online-only Data Supplement), suggesting that it is independent of SAH-induced intracranial hypertension.
Thereafter, we studied the permeability of the paravascular CSF circulation pathways 24 hours after SAH. To this aim, we injected a high-molecular-weight fluorescent dye (FITC-Dextran) in the cisterna magna. We first confirmed by histological analyses that this dye accumulates in the perivascular space after intracisternal injection ( Figure To test this hypothesis, we performed intraventricular injection of a fibrinolytic agent (tissue-type plasminogen activator) 15 minutes after hemorrhage onset and evaluated the glymphatic perfusion at 24 hours. According to our hypothesis, intraventricular injection of tissue-type plasminogen activator improved glymphatic perfusion in SAH mice as compared with control saline-treated animals ( Figure 2C ).
Finally, to investigate the effect of glymphatic blockade on the brain clearance rate of small-molecular-weight compounds, we measured the clearance of DOTA-Gd from sham and SAH mice by serial T1-weighted MRI. As shown in Figure VI in the online-only Data Supplement, DOTA-Gd clearance from the striatum of SAH animals was slower than in control animals. This result suggested that glymphatic blockade by fibrin after SAH reduces waste clearance from the brain parenchyma. Interestingly, the clearance rate was diminished in SAH animals but was not completely abolished, suggesting the existence of other mechanisms driving DOTA-Gd clearance.
Ischemic Stroke Decreased Paravascular CSF Circulation
To study the impact of ischemic stroke on the glymphatic function, we induced embolic ischemic stroke in mice and studied the glymphatic system function by MRI and histofluorescence 3 and 24 hours after right middle cerebral artery occlusion. Interestingly, we noticed a blockade of the right glymphatic perfusion 3 hours after middle cerebral artery occlusion, as revealed by MRI ( Figure 3A and 3B) and histology ( Figure 3C and 3D). Again, glymphatic perfusion at 3 hours poststroke remained impaired after bilateral craniectomy (Figure VII in the online-only Data Supplement). At 24 hours after stroke onset, the glymphatic system function appeared normal. Notably, angiographies performed at the time of glymphatic imaging revealed that the middle cerebral artery were repermeabilized in all mice 24 hours after stroke onset (not shown). Thus, these 
Glymphatic Imaging in Other Experimental Models of Cerebrovascular Diseases
In another set of experiments, we performed glymphatic imaging 24 hours after common carotid artery occlusion or intracerebral hemorrhage. Neither common carotid artery occlusion nor intracerebral hemorrhage influenced paravascular circulation of the CSF ( Figure VIII in the online-only Data Supplement).
Discussion
The current study demonstrates that the glymphatic system function can be evaluated in living mice using MRI coupled 
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to a minimally invasive injection of DOTA-Gd in the cisterna magna. Our key finding is that the glymphatic system is severely impaired after SAH and in the acute phase of ischemic stroke, independently of intracranial hypertension. Current evidence suggests that the glymphatic system plays an important role in cerebral waste clearance. 6 Once impaired, the accumulation of metabolites within the parenchyma might lead to brain injury. This event could be particularly relevant during delayed cerebral ischemia occurring after SAH. 7 Moreover, whether prolonged glymphatic dysfunction may promote vasospasm or microcirculatory impairment deserves further investigations. 8 If true, restoring glymphatic perfusion by intraventricular fibrinolysis may be effective to improve patient outcome.
During the acute phase of ischemic stroke, the observed reduction of glymphatic perfusion may prevent adequate clearance of excitatory neurotransmitters (and other deleterious molecules) and promote neuronal death. The mechanisms responsible for this blockade remain elusive but may include: (1) a decrease of the arterial pulsation because of vessel occlusion 9 or (2) the occlusion of the perivascular space because of compression by the intravascular thrombus. According to both hypotheses, the glymphatic perfusion appeared normal 24 hours after ischemic stroke, when the middle cerebral artery was repermeabilized. Consequently, beside restoration of arterial patency, intravenous thrombolysis may improve glymphatic perfusion in ischemic stroke patients. Our results support the findings from a recent study showing reduced interstitial fluid drainage after microstroke using 2-photon microscopy. 10 In contrast, we failed to confirm the reduction of the ipsilateral glymphatic flow after carotid occlusion. 9 Differences in the delay between arterial ligation and tracer administration (0.5 versus 24 hours) may explain this discrepancy.
Conclusions
In conclusion, we demonstrate that the glymphatic system is severely impaired after SAH and in the acute phase of ischemic stroke. Further studies are warranted to investigate the impact of such dysfunctions on neurological outcome. Notably, tissuetype plasminogen activator administration, either by removing perivascular fibrin after SAH or by restoring arterial patency after ischemic stroke, may improve glymphatic perfusion.
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Supplementary Methods

Animals
Experiments complied with the European Directives and the French Legislation on Animal Experimentation. All the experiments were performed in male swiss mice (35-40g; CURB, Caen, France) anesthetized with isoflurane (2%) in 70%/30% NO2/O2. Body temperature was maintained at 37°C with a rectal temperature probe and homoeothermic heating pad. Mice received subcutaneous buprenorphine (0.05 mg/kg) at the time of the first anesthesia and during the imaging procedure at +24 hours, when appropriate.
Intracisternal injection
The function of the glymphatic system was evaluated either by T1-weighted MRI after intracisternal DOTA-Gd (Dotarem) microinjection (1 µL over 1 minute) or by histofluorescence after intracisternal sodium fluorescein (NaF) or FITC-Dextran microinjection (1 µL over 1 minute). To inject the tracer intracisternaly, we modified a previously reported method 1 by using a pulled haematological glass micropipette (diameter= ~80 µm) instead of a 30 gauge needle (diameter= 311 µm) ( Supplementary Fig. 1 ). This allowed us to perform a single small volume injection of contrast material without significant damage to the dura mater and thus, without CSF leakage. The micropipette was left in place for 1 additional minute and then the wound was closed.
Embolic ischemic stroke
To investigate the effect of ischemic stroke on paravascular CSF circulation, we wanted a model in which no intracranial vascular lesion was present. Moreover, the occlusive material should not exert excessive pressure on the middle cerebral artery (MCA) to avoid irrelevant blockade of para-arterial influx. Thus, we selected a model in which the occlusive material was endogenous and physiologically advanced from the right common carotid artery (CCA) to the MCA. Therefore, embolic ischemic stroke was induced in mice by mechanically promoting embolization of Ferric chloride (FeCl 3 )-triggered thrombi (30% m/v, 1 minute application) from the right CCA to the MCA. Mice were included in the study if magnetic resonance angiogram (MRA) performed 60 minutes after embolization showed proximal MCA occlusion (~60% of the mice performed were included for subsequent analyses). Glymphatic imaging was performed 3 hours and 24 hours (in two separate groups of mice) after ischemia onset. Notably, all the mice showed spontaneous recanalization of the MCA at +24 hours. To perform sham animals, the right CCA was exposed but only saline was applied on the artery. All the performed mice had two angiographies: one was performed at +1 hour and constituted an inclusion criteria and another one at the time of glymphatic imaging (+3 or +24 hours). According to our findings, all the mice that presented proximal MCA occlusion at +1 hour, also presented proximal MCA occlusion at +3 hours. Therefore, there was no spontaneous recanalization between +1 and +3 hours. In contrast, all the mice performed presented recanalization at +24 hours, suggesting that spontaneous recanalization occured between +3 and +24 hours after ischemic stroke onset.
Common carotid artery occlusion
Left common carotid artery occlusion (CCAo) was performed as previously described 2 . Briefly, the left CCA was exposed and double-ligated with 6-0 silk sutures. All the mice were included in the final analyses.
Intracerebral hemorrhage
Intracerebral hemorrhage (ICH) was induced by collagenase injection as previously described 3 . Briefly, using a stereotactic frame a pulled hematological micropipette was inserted into the right striatum at bregma: 0.5 mm; mediolateral: 2.5 mm; dorsoventral: 3 mm. Then, 0.5 μL of saline containing 0.04 IU of collagenase VII-S (Sigma-Aldrich, L'Isled'Abeau, France) was injected. All the mice were included in the final analyses.
Subarachnoid Hemorrhage
Subarachnoid hemorrhage (SAH) was induced by injection of fresh arterial blood into the prechiasmatic cistern 4 . The mouse was placed within a stereotactic frame. A hole was drilled in the skull 4.5 mm anterior to the bregma, after we had observed and avoided the superior sagittal sinus. A 30-gauge needle was advanced at a 40° angle for 5 mm until the skull base was touched. It was withdrawn from 0.5-1 mm, so that the tip was in the prechiasmatic cistern. Arterial blood was withdrawn from the left ventricle of another anesthetized mouse using a 25 gauge needle. 50 µL of blood were manually injected through the 30 gauge needle in 15 seconds. We chose the volume of 50 µL instead of 100 µL 4 in order to induce mild subarachnoid hemorrhages with fast recovery of the mice and no mortality. For sham animals, the same procedure was followed, except that the intracisternal injection solution was made of saline. All the mice were included in the final analyses.
Intraventricular fibrinolysis
To induce intraventricular fibrinolysis, tissue-type plasminogen activator (tPA, 3 µg in 1 µL) was injected in the right lateral ventricle (coordinate: AP +0mm; LR +1.75mm ; DV = -3mm) 15 minutes after SAH. Control animals received intraventricular saline (1 µL).
DOTA-Gd clearance
SAH was induced in mice and 24 hours thereafter, we performed an intrastriatal injection of 1 µL of a diluted solution of DOTA-Gd. Then, mice underwent two MRI sessions at +1 minute and +60 minutes after in situ DOTA-Gd injection to measure DOTA-Gd clearance from the brain. Data were quantified as a signal intensity ratio between the ipsilateral (injected) and the contralateral (control) striatum.
Craniectomy
Mice were anesthetized at +1 hour after ischemic stroke onset or at +22 hours post SAH with isoflurane (2%) and placed in a stereotaxic frame to immobilize the head. An injection of buprenorphine (0.05 mg/kg) was performed subcutaneously in the neck. Then, a skin incision was performed between the two ears to expose the skull. A large craniectomy was performed (diameter =~1cm) in the center of the skull by drilling. Animals that presented a damaged dura matter after the procedure were excluded. After craniectomy, the wound was stitched using 5.0 silk sutures and the mice were allowed to recover.
MRI experiments
MRI was performed on a 7T Pharmascan MRI system (Bruker, Germany) equipped with surface coils. High-resolution 3D T1-weighted imaging was performed with a Fast Low Angle Shot (FLASH) sequence with parameters set as follow: TR/TE 15/3.57 ms, Angle= 25°, Field of View= 20*17*14.4 mm, Matrix= 256*218*96 leading to a resolution of 78*78*0.15 µm, acquisition time= 5m 14s. T2-weighted imaging and Diffusion weighted imaging were performed as previously described 5 . Quantification of the images was performed using ImageJ (1.48, NIH) in a blinded manner and regions of interest were set as described on supplementary figure 2.
Immunohistochemistry
Deeply anesthetized mice were transcardially perfused with cold heparinized saline (15 mL) followed by 150 mL of fixative (PBS 0.1 M. pH 7.4 containing 2% paraformaldehyde and 0.2% picric acid). Brains were post-fixed (18 hours; 4°C) and cryoprotected (sucrose 20% in veronal buffer; 24 hours; 4°C) before freezing in Tissue-Tek (Miles Scientific, Naperville, IL, USA). Cryomicrotome-cut transversal sections (8-10 µm) were collected on poly-lysine slides and stored at -80°C before processing. Sections were co-incubated overnight with goat anticollagen-type IV (1:1500, Col IV; Southern Biotech), chicken anti-GFAP (1:8000; Abcam) or sheep anti-fibrinogen (1:4000, purified Serum from sheep immunized with fibrinogen) in veronal buffer (pH 7.4). Primary antibodies were revealed using Fab'2 fragments of Donkey anti-goat, sheep or chicken IgG linked to FITC or TRITC (1:500, Jackson ImmunoResearch, West Grove, USA). Washed sections were coverslipped with antifade medium containing DAPI and images were digitally captured using a Leica DM6000 microscope-coupled coolsnap camera and visualized with Metavue 5.0 software (Molecular Devices, USA) and further processed using ImageJ 1.48 software (NIH). Measurement of fluorescence intensity was performed using ImageJ using unprocessed images (mean fluorescence of the whole image). Three different slices per mouse were selected randomly in the target area and the mean fluorescence was computed. Image acquisition parameters were set at the same values for all the animals (Acquisition time= 1000 ms).
Statistics
Results are the mean +/-SD. Statistical analyses were performed using the Kruskall-Wallis test followed by post hoc comparison with the Mann-Whitney U test. To investigate whether reduced glymphatic perfusion in the forebrain after ischemic stroke may be explained by an increase in intracranial pressure, we performed glymphatic imaging at 3 hours after stroke onset in craniectomized animals. (A) Top left: Representative DWI-weighted images of a craniectomized mouse 1 hour after stroke onset (and 2 hours before glymphatic imaging). The lack of brain herniation suggests that the intracranial pressure is not significantly increased in this model at this time point. Top right: Representative angiography after craniectomy showing proximal occlusion of the right MCA after thrombus embolization. Bottom: Representative T1-weighted images of the glymphatic system after intracisternal DOTA-Gd injection in a mouse 3 hours after stroke onset revealing an impaired glymphatic perfusion in the ischemic cortex. (C) Corresponding quantification (n=4). The glymphatic system remained impaired despite craniectomy.
